A patient-reported symptom tracking method used for patients with cancer has now been adapted for patients with COVID-19. The first clinical case series showed that famotidine may help COVID-19 patients with mild to moderately severe symptoms.
source https://www.sciencedaily.com/releases/2020/06/200605004329.htm
Friday, 5 June 2020
Related Posts
NIST laser 'comb' systems now measure all primary greenhouse gases in the airResearchers at NIST have upgraded their laser frequency-comb instrumen… Read More
Mixing it up: A low-cost way to make efficient, stable perovskite solar cellsBy using a fluid mixing process instead of expensive, high-temperature… Read More
Employed individuals more likely to contract the flu, study showsResearchers found that employed individuals, on average, are 35.3% mor… Read More
Embryo freezing for IVF appears linked to blood pressure problems in pregnancyA large cohort study drawn from the national IVF registry of France, w… Read More
Better method to predict offshore wind powerResearchers have developed a machine learning model using a physics-ba… Read More
New research lifts the clouds on land clearing and biodiversity lossA new mathematical model has been developed to uncover land clearing w… Read More
0 comments: